medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (6)


Bone metastases as the initial presentation of hepatocellular carcinoma. Two case reports and a literature review

Ruiz-Morales JM, Dorantes-Heredia R, Chable-Montero F, Vazquez-Manjarrez S, Méndez-Sánchez N, Motola-Kuba D

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 838-842
Archivo PDF: 221.17 Kb.


RESUMEN

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2011; 53: 1020-2.

  2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245.

  3. Manghisi G, Elba S, Mossa A, Giorgio A, Aloisio V, Perrotta A, Tardio B, et al. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751.

  4. Motola-Kuba D, Zamora-Valdés D, Uribe M, Méndez-Sánchez N. Hepatocellular carcinoma. An overview. Ann Hepatol 2006; 5: 16-24.

  5. Sugano S, Miyoshi K, Suzuki T, Kawafune T, Kubota M. Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization. Am J Gastroenterol 1994; 89: 184.

  6. Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY, Yoon HK, Sung KB, et al. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? J Gastroenterol Hepatol 2011; 26: 145-54.

  7. Qureshi SS, Shirkhande SV, Borges AM, Shukla Parul J. Chest wall metastases from unknown primary hepatocellular carcinoma. J Postgrad Med 2005; 51: 41-2.

  8. Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, Wakasugi H, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2001; 13: 1083-8.

  9. Nakamura N, Igaki H, Yamashita H, Shiraishi K, Tago M, Sasano N, Shiina S, et al. A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC). Jpn J Clin Oncol 2007; 37: 38-43.

  10. Nayak NC. Hepatocellular carcinoma-a model of human cancer: clinico-pathological features, etiology and pathogenesis. Indian J Pathol Microbiol 2003; 46: 1-16.

  11. Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, et al. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 2007; (5): 1016.

  12. Piccirillo M, Granata V, Albino V, Palaia R, Setola SV, Petrillo A, Tatangelo F, et al. Can hepatocellular carcinoma (HCC) produce unconventional metastases? Four cases of extrahepatic HCC. Tumori 2013; 99(1): e19-e23.

  13. Liaw CC, Ng KT, Chen TJ, Liaw YF. Hepatocellular carcinoma presenting as bone metastasis. Cancer 1989; 64: 1753-7.

  14. Fukusato T, Aoyama H, Mori W. Age and sex differences in bone metastasis of hepatocellular carcinoma in Japanese autopsy cases. Gastroenterol Jpn 1989; 24: 127-34.

  15. Miura T, Hirabuki N, Kozuka T. Cranial metastasis from hepatocellular carcinoma. Clin Radiol 1990; 42: 445-6.

  16. Radwan NA, Ahmed NS. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Diagn Pathol 2012; 7: 149.




2020     |     www.medigraphic.com